ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL

ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL

Bibliographic Details
Main Authors: Fábio Vieira TEIXEIRA, Paulo Gustavo KOTZE, Adérson Omar Mourão Cintra DAMIÃO
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
Series:Arquivos de Gastroenterologia
Subjects:
Medicamentos biossimilares
Doença de Crohn
Colite ulcerativa
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000200060&lng=en&tlng=en
id doaj-773973a1ef0d4121bf98939f04d691de
record_format Article
spelling doaj-773973a1ef0d4121bf98939f04d691de2020-11-24T21:27:44ZengInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)Arquivos de Gastroenterologia1678-4219532606110.1590/S0004-28032016000200002S0004-28032016000200060ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZILFábio Vieira TEIXEIRAPaulo Gustavo KOTZEAdérson Omar Mourão Cintra DAMIÃOhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000200060&lng=en&tlng=enMedicamentos biossimilaresDoença de CrohnColite ulcerativa
collection DOAJ
language English
format Article
sources DOAJ
author Fábio Vieira TEIXEIRA
Paulo Gustavo KOTZE
Adérson Omar Mourão Cintra DAMIÃO
spellingShingle Fábio Vieira TEIXEIRA
Paulo Gustavo KOTZE
Adérson Omar Mourão Cintra DAMIÃO
ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
Arquivos de Gastroenterologia
Medicamentos biossimilares
Doença de Crohn
Colite ulcerativa
author_facet Fábio Vieira TEIXEIRA
Paulo Gustavo KOTZE
Adérson Omar Mourão Cintra DAMIÃO
author_sort Fábio Vieira TEIXEIRA
title ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
title_short ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
title_full ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
title_fullStr ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
title_full_unstemmed ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL
title_sort anvisa approves the first biosimilar monoclonal antibody based on comparability in brazil
publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
series Arquivos de Gastroenterologia
issn 1678-4219
topic Medicamentos biossimilares
Doença de Crohn
Colite ulcerativa
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032016000200060&lng=en&tlng=en
work_keys_str_mv AT fabiovieirateixeira anvisaapprovesthefirstbiosimilarmonoclonalantibodybasedoncomparabilityinbrazil
AT paulogustavokotze anvisaapprovesthefirstbiosimilarmonoclonalantibodybasedoncomparabilityinbrazil
AT adersonomarmouraocintradamiao anvisaapprovesthefirstbiosimilarmonoclonalantibodybasedoncomparabilityinbrazil
_version_ 1725973553583489024

Similar Items